Nifty Pharma index outpaced the benchmark index which slipped more than 1 per cent.
Aurobindo Pharma, Divi's Laboratories and Sun Pharmaceutical Industries Ltd., too, were among the top performers.
Nifty Pharma index, the largest gainer among sectoral indices, was up 1.7% as compared to 0.17% decline in Nifty 50 index at 09:36 am.
Biocon (NS:BION) Limited (BIOCON), Close: 708.40 (+1.80), Sep 27, 2018 An approximate horizontal trend channel in the medium-term is broken up. Trading inside a more neutral zone...
Last Trading Session: Indian Stock Market opened flat with positive bias exactly as predicted. EquityPandit predicted that Nifty is still positive but consolidation would be seen...
Last Trading Session: Indian Stock Market opened gap positive as predicted by EquityPandit. EquityPandit predicted that Indian Stock Market is still in positive zone and Nifty...
|Type||5 mins||15 mins||Hourly||Daily||Monthly|
|Technical Indicators||BUY||Strong Buy||Strong Buy||Strong Sell||Strong Buy|
|Summary||Buy||Strong Buy||Strong Buy||Neutral||Strong Buy|
Filter Table By:
|Pattern||Timeframe||Reliability||Candles Ago||Candle Time|
|Doji Star Bearish||1D||Current|
|Morning Doji Star||1W||Current|
|Bullish doji Star||1W||1||Oct 07, 2018|
|Evening Doji Star||1W||2||Sep 30, 2018|
|Doji Star Bearish||1W||3||Sep 23, 2018|
Biocon Limited is a biopharmaceutical company. The Company focuses to reduce therapy costs of chronic diseases like autoimmune, diabetes, and cancer. Through its products and research services it is enabling access to affordable healthcare for patients, partners and healthcare systems across the globe. The Company has developed and taken a range of Novel Biologics, Biosimilars, differentiated Small Molecules and affordable Recombinant Human Insulin and Analogs from Lab to Market. The Company’s brands include INSUGEN (rh-insulin), BASALOG (Glargine), CANMAb (Trastuzumab), BIOMAb-EGFR (Nimotuzumab) and ALZUMAb (Itolizumab), an anti-CD6 monoclonal antibody. It has a pipeline of Biosimilars and Novel Biologics at various stages of development, including Insulin Tregopil, an oral insulin analog.Read More
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.